Key facts
- It has raised $14.5M; the latest was Early Stage VC ($14.5M) in Apr 2026.
- Notable investors include Fuzhe Capital, Hongsheng Capital, Ningbo Tianyi Medical Appliance.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Tianhuiyi
- ·The full record, as it builds
Funding rounds
No funding rounds for Tianhuiyi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tianhuiyi
Manufacturer of blood purification and dialysis-related medical systems designed to support acute and chronic renal care treatment and related therapeutic applications. The company offers integrated blood purification, dialysis equipment, and specialty therapeutic systems with cross-border regulatory certifications and end-to-end clinical treatment capabilities, enabling hospitals and healthcare providers across global renal care markets to deliver comprehensive, continuous patient care.
- Sector
- Healthcare
- HQ
- Ningbo, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Tianhuiyi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tianhuiyi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tianhuiyi in its N-PORT filings yet. We sweep new filings monthly.